Establishing Intratumoral Modulation Therapy as a New Treatment Modality for High Grade Gliomas

Glioblastoma (GBM) is the most common and lethal primary brain cancer in adults despite aggressive treatments with surgery and chemo-radiation. Advances in electrotherapeutics offer a foundation for developing new treatment modalities that exploit an innate vulnerability of glioblastoma (GBM). Low intensity, non-ablative electric fields are innocuous to normal neural structure, but incite GBM cell apoptosis by putatively disrupting cytokinesis and transmembrane ion homeostasis. Our collaborative research group is pioneering a new electrotherapeutic technology for GBM called Intratumoral Modulation Therapy (IMT) which uses customized, implanted bioelectrodes to deliver sustained, titratable and focused therapeutic electric fields into tumor-affected brain regions. My work has confirmed and expanded the group’s previous in vitro evidence of IMT efficacy against GBM and diffuse intrinsic pontine glioma (DIPG) and has demonstrated potent anti-neoplastic, pro-apoptotic effects of IMT in vitro without significant impact on non-cancerous post-mitotic neurons. The co-application of IMT also potentiates the benefits of chemotherapy and gene therapy. We have created a robust in vivo IMT model using allograft GBM cells in Fischer rats to test the efficacy of IMT in vivo. The GBM animal studies to date have demonstrated proof-of-concept efficacy of IMT against GBM using rudimentary, single-contact bioelectrodes. However, single-contact electrodes cannot adequately accommodate the entire tumor or GBM resection bed where recurrence is otherwise inevitable. In order to translate this technology to clinical use, new special purpose bioelectrodes must be designed and tested to optimize and contour IMT coverage. This thesis yielded key insight into the bioelectrode configuration and treatment settings for effective and safe IMT delivery in GBM and DIPG. Advances in this technology will facilitate clinical translation of IMT as a critically needed therapy for these devastating brain cancers.

Name thesis:degree_name

Ph D

Discipline thesis:degree_discipline

Anatomy and Cell Biology

Grantor dc:publisher

The University of Western Ontario

Year dc:date.issued

2021

Author dc:creator

• Deweyert, Andrew M.A.

Advisors dc:contributor.advisor

• Hebb, Matthew O.
• Schmid, Susanne

• Glioblastoma
• Diffuse Intrinsic Pontine Glioma
• Electrotherapy
• Intratumoural Modulation Therapy
• Neuro-oncology
• High Grade Glioma

Language dc:language.iso

en_ca

Handle dc:identifier.uri

https://hdl.handle.net/20.500.14721/31384

OAI identifier oai:identifier

oai:uwo.scholaris.ca:20.500.14721/31384